Beijing Innocare Pharma Tech Co., Ltd.

This study is testing whether an oral medication called ICP-488 can safely reduce the severity of skin rashes in people with cutaneous lupus erythematosus (CLE), a form of lupus that affects the skin. About 105 adults with moderate-to-severe skin lupus will be randomly assigned t…

This study is testing an investigational drug called ICP-332 for adults with moderate to severe chronic hives that are not controlled by standard allergy medicines. The main goal is to see if the drug can safely reduce hive symptoms and itching over several weeks. Participants wi…